Articles by admin

No Picture
Trading Ideas

Trump's revenge: U.S. oil floods Europe, hurting OPEC and Russia

April 23, 2018 admin Comments Off on Trump's revenge: U.S. oil floods Europe, hurting OPEC and Russia

MOSCOW/LONDON (Reuters) – As OPEC’s efforts to balance the oil market bear fruit, U.S. producers are reaping the benefits – and flooding Europe with a record amount of crude. Russia paired with the Organization of the Petroleum Exporting Countries last year in cutting oil output jointly by 1.8 million barrels per day (bpd), a deal they say has largely rebalanced the market and one that has helped elevate benchmark Brent prices close to four-year highs. Now, the relatively high prices brought about by that pact, coupled with surging U.S. output, are making it harder to sell Russian, Nigerian …read more […]

No Picture
Trading Ideas

Investors Are Dumping Altria Group Inc Stock Without Looking at the Facts

April 23, 2018 admin Comments Off on Investors Are Dumping Altria Group Inc Stock Without Looking at the Facts

The usually reliable Altria Group Inc (NYSE:MO) is off to a horrific start this year, with MO stock shedding 18%. For technical analysts, the recent break below $60 was highly discouraging. In short, MO stock must regain its footing quickly due to the significant technical damage. …read more […]

Newsmakers

Check-Cap (NASDAQ: CHEKW) Regains Compliance With Nasdaq Minimum Bid Price Requirement

April 22, 2018 admin Comments Off on Check-Cap (NASDAQ: CHEKW) Regains Compliance With Nasdaq Minimum Bid Price Requirement

ISFIYA, Israel, April 19, 2018 Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced […]

Newsmakers

Abeona Therapeutics (NASDAQ:ABEO) Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

April 20, 2018 admin Comments Off on Abeona Therapeutics (NASDAQ:ABEO) Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

NEW YORK and CLEVELAND, April 20, 2018 – Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European […]